Cargando…
PB2070: IMMUNE RESPONSES AFTER SARS-COV-2 MRNA-VACCINATION AND INFECTION AT SINGLE CELL RESOLUTION IN PATIENTS WITH MULTIPLE MYELOMA
Autores principales: | Enssle, Julius C., Campe, Julia, Moter, Alina, Voit, Isabel, Gessner, Alec, Yu, Ika Weija, Wolf, Sebastian, Steffen, Björn, Oellerich, Thomas, Serve, Hubert, Bremm, Melanie, Huenecke, Sabine, Lohoff, Michael, Vehreschild, Maria, Rabenau, Holger F, Widera, Marek, Ciesek, Sandra, Rieger, Michael A, Imkeller, Katharina, von Metzler, Ivana, Ullrich, Evelyn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429099/ http://dx.doi.org/10.1097/01.HS9.0000975080.11813.df |
Ejemplares similares
-
Portraying Immunity to Sars-Cov-2 after mRNA-Vaccination in Patients with Multiple Myeloma
por: Enssle, Julius Christoph, et al.
Publicado: (2022) -
Enhanced but variant-dependent serological and cellular immune responses to third-dose BNT162b2 vaccination in patients with multiple myeloma
por: Enssle, Julius C., et al.
Publicado: (2022) -
COVID-19 in multiple-myeloma patients: cellular and humoral immunity against SARS-CoV-2 in a short- and long-term view
por: von Metzler, Ivana, et al.
Publicado: (2021) -
Severe impairment of T-cell responses to BNT162b2 immunization in patients with multiple myeloma
por: Enßle, Julius C., et al.
Publicado: (2022) -
PB2070: EFFICACY OF RITUXIMAB MAINTENANCE THERAPY IN ADVANCED-STAGE FOLLICULAR LYMPHOMA: A SINGLE-CENTER RETROSPECTIVE STUDY.
por: Amorós, C., et al.
Publicado: (2022)